The Apex Times
Above the Noise
Business Wire
BusinessCostco’s Shares Get a “Surprise” Label as Investors Look Back at the Past YearThe Apex TimesBusinessJPMorgan profit falls short of expectations as fixed-income trading revenue softensThe Apex TimesBusinessBank of America survey finds growing conviction that an AI “bubble” will emerge in 2027The Apex TimesBusinessUnitedHealth rises on strong Q3 results as investors weigh earnings and trim exposure to AI winnersThe Apex TimesBusinessNvidia Shares Dip as Broadcom and Microsoft News Filters Through the Chip SectorThe Apex TimesBusinessJohnson & Johnson lifts earnings guidance as pharma growth offsets a drag in medical devicesThe Apex TimesBusinessWall Street analysts weigh in on Adobe as markets eye the start of earnings seasonThe Apex TimesBusinessUnitedHealth shares rose in premarket as investors digested bank results, while chip stocks pressured Nasdaq futuresThe Apex TimesBusinessQnity leans on “local-for-local” production model to compete for more AI chip supply, report saysThe Apex TimesBusinessAMD and SK Hynix face different risks as investors weigh valuation versus competitionThe Apex TimesBusinessRaytheon wins $729 million for counter-drone system components tied to the LIDS programThe Apex TimesBusinessTripleLift becomes Uber Advertising’s first partner for U.S. offsite audience expansionThe Apex TimesBusinessCostco’s Shares Get a “Surprise” Label as Investors Look Back at the Past YearThe Apex TimesBusinessJPMorgan profit falls short of expectations as fixed-income trading revenue softensThe Apex TimesBusinessBank of America survey finds growing conviction that an AI “bubble” will emerge in 2027The Apex TimesBusinessUnitedHealth rises on strong Q3 results as investors weigh earnings and trim exposure to AI winnersThe Apex TimesBusinessNvidia Shares Dip as Broadcom and Microsoft News Filters Through the Chip SectorThe Apex TimesBusinessJohnson & Johnson lifts earnings guidance as pharma growth offsets a drag in medical devicesThe Apex TimesBusinessWall Street analysts weigh in on Adobe as markets eye the start of earnings seasonThe Apex TimesBusinessUnitedHealth shares rose in premarket as investors digested bank results, while chip stocks pressured Nasdaq futuresThe Apex TimesBusinessQnity leans on “local-for-local” production model to compete for more AI chip supply, report saysThe Apex TimesBusinessAMD and SK Hynix face different risks as investors weigh valuation versus competitionThe Apex TimesBusinessRaytheon wins $729 million for counter-drone system components tied to the LIDS programThe Apex TimesBusinessTripleLift becomes Uber Advertising’s first partner for U.S. offsite audience expansionThe Apex TimesBusinessCostco’s Shares Get a “Surprise” Label as Investors Look Back at the Past YearThe Apex TimesBusinessJPMorgan profit falls short of expectations as fixed-income trading revenue softensThe Apex TimesBusinessBank of America survey finds growing conviction that an AI “bubble” will emerge in 2027The Apex TimesBusinessUnitedHealth rises on strong Q3 results as investors weigh earnings and trim exposure to AI winnersThe Apex TimesBusinessNvidia Shares Dip as Broadcom and Microsoft News Filters Through the Chip SectorThe Apex TimesBusinessJohnson & Johnson lifts earnings guidance as pharma growth offsets a drag in medical devicesThe Apex TimesBusinessWall Street analysts weigh in on Adobe as markets eye the start of earnings seasonThe Apex TimesBusinessUnitedHealth shares rose in premarket as investors digested bank results, while chip stocks pressured Nasdaq futuresThe Apex TimesBusinessQnity leans on “local-for-local” production model to compete for more AI chip supply, report saysThe Apex TimesBusinessAMD and SK Hynix face different risks as investors weigh valuation versus competitionThe Apex TimesBusinessRaytheon wins $729 million for counter-drone system components tied to the LIDS programThe Apex TimesBusinessTripleLift becomes Uber Advertising’s first partner for U.S. offsite audience expansionThe Apex TimesBusinessCostco’s Shares Get a “Surprise” Label as Investors Look Back at the Past YearThe Apex TimesBusinessJPMorgan profit falls short of expectations as fixed-income trading revenue softensThe Apex TimesBusinessBank of America survey finds growing conviction that an AI “bubble” will emerge in 2027The Apex TimesBusinessUnitedHealth rises on strong Q3 results as investors weigh earnings and trim exposure to AI winnersThe Apex TimesBusinessNvidia Shares Dip as Broadcom and Microsoft News Filters Through the Chip SectorThe Apex TimesBusinessJohnson & Johnson lifts earnings guidance as pharma growth offsets a drag in medical devicesThe Apex TimesBusinessWall Street analysts weigh in on Adobe as markets eye the start of earnings seasonThe Apex TimesBusinessUnitedHealth shares rose in premarket as investors digested bank results, while chip stocks pressured Nasdaq futuresThe Apex TimesBusinessQnity leans on “local-for-local” production model to compete for more AI chip supply, report saysThe Apex TimesBusinessAMD and SK Hynix face different risks as investors weigh valuation versus competitionThe Apex TimesBusinessRaytheon wins $729 million for counter-drone system components tied to the LIDS programThe Apex TimesBusinessTripleLift becomes Uber Advertising’s first partner for U.S. offsite audience expansionThe Apex Times
Back to front
Moderna Sets Live Call for Third-Quarter 2026 Financial Results on Nov. 6
The Apex Times

THE APEX TIMES

Business/The Apex Times/Oct 13, 7:12 AM EDT

Moderna Sets Live Call for Third-Quarter 2026 Financial Results on Nov. 6

The biotechnology company will report its third-quarter 2026 results with a live conference call and webcast scheduled for 8:00 a.m. ET on Friday, November 6, 2026.

By The Apex Times Newsroom2 min readAI-assisted Apex article

Moderna said it will release its third-quarter 2026 financial results on Friday, November 6, 2026, and will host a live conference call and webcast beginning at 8:00 a.m. Eastern Time the same day.

The announcement, issued on October 13, 2026, did not provide additional detail on the quarter’s performance or guidance. Instead, it focused on the timing and logistics for the earnings event, indicating that investors will need to wait for the company’s results materials for revenue, profit or loss, and cash flow updates.

For shareholders and analysts, the call is typically where management discusses the quarter’s key drivers, including how product demand and manufacturing progress are evolving and what those trends imply for later periods. While Moderna did not spell out which topics it plans to emphasize, earnings calls for public biopharmaceutical companies commonly include commentary on business developments alongside financial metrics.

Moderna’s use of a live webcast means the event will be broadly accessible to investors who cannot attend by phone. The company’s statement places the webcast alongside the conference call rather than offering a delayed replay-only approach, which can matter for how quickly market participants can react once the numbers are released.

In the broader healthcare sector, earnings season remains a key checkpoint for biotech companies as investors try to separate near-term financial volatility from longer-term clinical and commercialization milestones. For firms like Moderna, whose business is closely tied to public immunization and respiratory-virus demand cycles, quarterly results can influence expectations for procurement activity, product mix, and operational cost trends.

It is still unclear from the announcement what specific line items or operational updates Moderna will highlight on the call. The company’s release did not include any forward-looking statements, targets, or quantified outlook in the posted information, so the likely direction and magnitude of any guidance or trend commentary must await the official earnings materials.

Investors will also look for any notes on risks and uncertainties that can accompany a biotech quarterly update, such as supply chain conditions, competitive dynamics in vaccines, and regulatory or manufacturing considerations. Those details are usually incorporated into management’s prepared remarks and Q&A, which are not provided ahead of time in the scheduling notice.

Why It Matters

  • The earnings release date sets the schedule for when investors can assess Moderna’s most recent operating and financial performance.
  • The live call and webcast give management a platform to contextualize results and address questions from investors shortly after the numbers are issued.
  • For a vaccine-focused biotech, quarterly updates can quickly shift market expectations around demand patterns and operational progress.

Sources

Key Facts

  • Moderna announced it will report third-quarter 2026 financial results on Friday, November 6, 2026.
  • A live conference call and webcast are scheduled for 8:00 a.m. Eastern Time on November 6, 2026.
  • The October 13, 2026 announcement focused on the event timing and did not provide quarterly performance details or outlook.

Healthcare Related